Outlook Therapeutics, Inc.OTLKNASDAQ

Revenue (LTM)

$1M

Net Income (LTM)

$-62M

+17.2% YoY

Free Cash Flow

$-51.8T

Revenue CAGR (5Y)

—

—Marginsstable

FCF($51829.4B)

Unprofitable

Metric	Sep 21	Sep 22	Sep 23	Sep 24	Sep 25
Revenue	0	0	0	0	1
Gross Profit	-0	-0↑21.9%	-0↑78.4%	-0↓157.7%	1↑677.2%
Operating Income	-52	-63↓21.9%	-53↑15.8%	-72↓35.0%	-67↑6.5%
Net Income	-53	-66↓24.2%	-59↑10.7%	-75↓27.8%	-62↑17.2%
EBITDA	-52	-64↓24.9%	-57↑10.8%	-72↓25.7%	-64↑11.8%
EPS Diluted	-6.96	-6.23↑10.5%	-4.72↑24.2%	-4.06↑14.0%	-1.79↑55.9%

Metric	Sep 21	Sep 22	Sep 23	Sep 24	Sep 25
Cash & Equivalents	14	17↑20.2%	23↑34.5%	15↓36.2%	8,083,085↑54148715.4%
Total Current Assets	22	28↑28.0%	31↑12.6%	27↓11.5%	17,388,969↑63426169.9%
Total Assets	23	29↑25.1%	32↑13.2%	29↓10.8%	18,584,183↑64476476.7%
Total Current Liabilities	7	20↑192.2%	47↑136.9%	43↓8.9%	45,814,605↑107662861.8%
Total Liabilities	18	20↑8.7%	47↑136.2%	102↑118.0%	50,771,844↑49825230.1%
Total Equity	5	9↑89.6%	-14↓265.3%	-73↓406.1%	-32,187,661↓44046421.9%
Total Debt	12	11↓7.9%	36↑224.5%	30↓16.4%	247,698↑832839.1%
Net Debt	-3	-6↓150.1%	12↑288.9%	15↑21.8%	-7,835,387↓52905117.2%

Metric	Sep 21	Sep 22	Sep 23	Sep 24	Sep 25
Operating Cash Flow	-54	-57↓4.5%	-43↑24.2%	-69↓60.1%	-51,829,437↓75340109.9%
Capital Expenditure	0	0	0	0	-0
Free Cash Flow	-54	-57↓4.5%	-43↑24.2%	-69↓60.1%	-51,829,437↓75340109.9%
Stock-Based Comp	5	8↑57.8%	6↓28.1%	5↓2.9%	8,897,887↑165230765.6%
Net Change in Cash	2	3↑50.4%	6↑105.4%	-8↓241.2%	-6,844,453↓80861123.7%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance